Active Ingredient: LIDOCAINE; PRILOCAINE
Proprietary Name: EMLA
Dosage Form; Route of Administration: CREAM; TOPICAL
Strength: 2.5%;2.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N019941
Product Number: 001
Approval Date: Dec 30, 1992
Applicant Holder Full Name: TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC
Marketing Status:
Discontinued
Patent and Exclusivity Information